Hemophilia trial finds promising cure

A gene-therapy trial by London researchers has seen remarkable success in finding a long-term cure for hemophilia A....

Posted: Dec 14, 2017 8:05 PM
Updated: Dec 14, 2017 8:05 PM

A gene-therapy trial by London researchers has seen remarkable success in finding a long-term cure for hemophilia A.

The trial, by researchers at Barts Health NHS (National Health Service) Trust and Queen Mary University of London, used gene therapy to inject one dose of a missing gene in patients with the condition, and the gene continued functioning in the body for more than a year.

Hemophilia is a hereditary genetic condition

Patients do not have the gene allowing blood to clot

There is no known permanent cure

New gene-therapy trial finds long-term cure

This is the first successful gene therapy to treat the condition.

Hemophilia is a hereditary genetic disorder, mostly affecting men, causing people to have low levels of clotting factor VIII, needed for their blood to clot.

Lack of the protein factor results in excessive bleeding from even minor injuries and can cause internal bleeding, which is life-threatening.

To date, there is no permanent cure for hemophilia, and patients have to take multiple weekly injections of clotting factor VIII to prevent and control bleeding.

"I'm very optimistic that we can deliver long-term treatment benefits," said John Pasi, Haemophilia Centre director at Barts Health NHS Trust and lead author of the study published Saturday in the New England Journal of Medicine.

"To say that it's going to be an absolute cure would be a bit rash, but I'm extremely optimistic that we will follow these patients and hopefully see great results continuing."

Record success in trial

More than 400,000 people around the world are estimated to suffer from hemophilia A, which is six times as common as hemophilia B, according to an accompanying editorial.

Type A sufferers lack factor VIII clotting protein, while those with type B lack factor IX.

In the UK, where the study was conducted, around 2,000 people suffer from severe hemophilia A.

During the trial, 13 patients received high-dose injections containing a copy of the gene that in turn codes the missing clotting protein. The patients were followed for 19 months to monitor success.

All 13 patients were off their treatment one year on, while 11 showed near-normal levels of the clotting protein and the remaining two showed stable levels, said Pasi.

The only side-effect Pasi said his team noticed was a sudden spike in liver enzymes, by almost three times. This did not result in external symptoms and eventually stabilized.

"We're trying to understand why [the spike] might happen but it's something that's fairly well recognized across gene therapy," he adds.

Breakthrough in curing hemophilia

Treatiing people with hemophilia A is very expensive, and the patients themselves face numerous lifestyle hurdles.

"The clotting factors are incredibly expensive, costing about -100,000 ($130,000) per patient per year, without ancillary care," said Simon Waddington, reader in gene transfer technology at University College London, who was not involved in the trial.

"They inject the factors and of course, you have peaks and drops in the circulatory levels of the factors so they are at risk of bleeding through their joints when the levels drop out."

With gene therapy, he explained, a single injection could provide the steady levels needed, and be more cost-effective.

Jake Omer, a father of two, was diagnosed with hemophilia A when he was two years old and suffers from arthritis in his ankles because of repeated internal bleeding. Participation in the trial has dramatically changed his life.

"I now have hope for my future. It is incredible to now hope that I can play with my kids, kick a ball around and climb trees well into my kids' teenage years and beyond," he said in a statement.

Gene therapy has high success

"Gene therapy has now turned the corner completely in terms of showing incredible results in a variety of different early clinical trials," said Waddington.

"For this trial, it is delightful that such high levels [of success] have been achieved because factor VIII has always been considered a much tougher target using gene therapy... [because it is a] more difficult molecule to manipulate."

Another common side-effect of gene therapy is an immune response to the injections that some patients have, he added. This can be countered using steroids or immune suppressants, to prevent the body from flushing the gene out.

Pasi regards durability as the big question in this trial -- the only other hemophilia trial on humans, done seven years ago, has continued to show stability, he said, which makes him hopeful.

The team is in talks with BioMarin Pharmaceutical, which manufactured the injection for this study, for investment in larger facilities.

They aim to expand to patients in Europe, the US, Africa and South America, with 60 new patients in the next trial.

Indiana Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 48201

Reported Deaths: 2693
CountyConfirmedDeaths
Marion11624683
Lake5146242
Elkhart328546
Allen2762129
St. Joseph194366
Cass16389
Hamilton1552101
Hendricks1403100
Johnson1278118
Porter72837
Tippecanoe7158
Madison65864
Clark65144
Bartholomew58544
Howard57557
LaPorte57326
Kosciusko5464
Vanderburgh5226
Marshall4924
Noble47828
Jackson4703
LaGrange4708
Hancock44835
Boone44243
Delaware44250
Shelby42525
Floyd37944
Morgan32931
Grant29426
Monroe29428
Montgomery29420
Clinton2892
Dubois2736
Henry26315
White26310
Decatur25032
Lawrence24425
Dearborn23623
Vigo2348
Warrick21429
Harrison21322
Unassigned193193
Greene18832
Miami1822
Jennings17611
Putnam1698
DeKalb1624
Scott1607
Daviess14317
Wayne1386
Orange13623
Steuben1292
Perry1279
Franklin1248
Jasper1212
Ripley1167
Wabash1122
Carroll1102
Fayette997
Newton9810
Starke933
Whitley925
Huntington812
Gibson802
Randolph794
Jefferson722
Wells721
Fulton701
Jay680
Washington671
Knox640
Pulaski641
Clay604
Rush583
Adams501
Benton480
Owen471
Sullivan441
Brown391
Posey390
Spencer381
Blackford372
Crawford320
Tipton321
Fountain312
Switzerland270
Parke230
Martin220
Ohio170
Vermillion140
Warren141
Union130
Pike110

Ohio Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 57150

Reported Deaths: 2911
CountyConfirmedDeaths
Franklin10271422
Cuyahoga7724373
Hamilton5924197
Marion273238
Lucas2723302
Pickaway219141
Summit2131206
Montgomery198126
Mahoning1825232
Butler157644
Columbiana130360
Stark1107112
Lorain102167
Trumbull93965
Warren83921
Clark7659
Delaware56815
Fairfield55916
Tuscarawas55210
Belmont54622
Medina51632
Lake49718
Licking47712
Miami46331
Portage44058
Ashtabula43344
Wood42151
Geauga40542
Clermont4006
Wayne36251
Richland3375
Allen31540
Mercer2818
Greene2519
Darke24825
Erie24222
Holmes2313
Huron2152
Madison1958
Ottawa14323
Crawford1355
Sandusky13414
Washington13220
Putnam12815
Ross1243
Hardin12312
Morrow1161
Auglaize1064
Coshocton972
Monroe8917
Jefferson872
Union851
Muskingum831
Hancock781
Hocking788
Preble731
Guernsey703
Lawrence700
Williams702
Clinton680
Shelby684
Logan621
Fulton610
Ashland591
Carroll593
Wyandot586
Athens561
Brown561
Knox511
Defiance503
Fayette460
Highland451
Champaign401
Scioto380
Perry341
Van Wert340
Seneca332
Henry290
Jackson230
Paulding230
Pike230
Adams221
Vinton222
Gallia171
Harrison121
Meigs120
Morgan110
Noble110
Unassigned00
Fort Wayne
Clear
72° wxIcon
Hi: 93° Lo: 70°
Feels Like: 72°
Angola
66° wxIcon
Hi: 92° Lo: 68°
Feels Like: 66°
Huntington
Clear
71° wxIcon
Hi: 91° Lo: 69°
Feels Like: 71°
Decatur
Clear
70° wxIcon
Hi: 92° Lo: 70°
Feels Like: 70°
Van Wert
Clear
70° wxIcon
Hi: 93° Lo: 71°
Feels Like: 70°
Few Storms Tuesday
WFFT Radar
WFFT Temperatures
WFFT National

Community Events